{"id":36987,"date":"2019-03-06T08:00:00","date_gmt":"2019-03-06T06:00:00","guid":{"rendered":"https:\/\/www.ipsen.com\/?post_type=press_release&#038;p=36987"},"modified":"2023-09-06T18:50:34","modified_gmt":"2023-09-06T16:50:34","slug":"ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/","title":{"rendered":"Ipsen pr\u00e9sentera les am\u00e9liorations apport\u00e9es \u00e0 la seringue pr\u00e9-remplie de Somatuline\u00ae Autogel\u00ae lors de la 16e Conf\u00e9rence annuelle de l\u2019ENETS (European Neuroendocrine Tumor Society)"},"content":{"rendered":"<p align=\"center\"><b>L\u2019abstract pr\u00e9sent\u00e9 \u00e0 l\u2019ENETS co\u00efncide avec le premier lancement europ\u00e9en<\/b><\/p>\n<p><b>Paris (France), 6 mars 2019 \u2013 Ipsen (Euronext : IPN ; ADR : IPSEY) a annonc\u00e9 aujourd\u2019hui le lancement europ\u00e9en d\u2019une nouvelle seringue pr\u00e9-remplie de Somatuline<\/b><b>\u00ae<\/b><b> Autogel<\/b><b>\u00ae<\/b><b> (lanr\u00e9otide) pour les patients souffrant de tumeurs neuroendocrines (TNE), d\u2019acrom\u00e9galie ou de sympt\u00f4mes associ\u00e9s au syndrome carcino\u00efde, ainsi que la pr\u00e9sentation, sous forme de poster, des r\u00e9sultats des \u00e9tudes sur le facteur humain qui ont appuy\u00e9 le d\u00e9veloppement de cette seringue (abstract n\u00b0H14) dans le cadre de l\u2019ENETS 2019.<\/b><b>1,2<\/b> \u00c0 partir du mois d\u2019avril 2019, les patients irlandais seront les premiers \u00e0 b\u00e9n\u00e9ficier de cette nouvelle seringue pr\u00e9-remplie pr\u00eate-\u00e0-l\u2019emploi. Ipsen a confirm\u00e9 son engagement \u00e0 mettre \u00e0 disposition des patients et professionnels de sant\u00e9 de toute l\u2019Europe, des \u00c9tats-Unis, du Canada, de l\u2019Australie et de la Nouvelle Z\u00e9lande cette nouvelle seringue pr\u00e9-remplie courant 2019, une fois les autorisations r\u00e9glementaires n\u00e9cessaires re\u00e7ues.<br \/>\nLa nouvelle seringue pr\u00e9-remplie de Somatuline\u00ae Autogel\u00ae est le r\u00e9sultat de plusieurs \u00e9tudes auxquelles ont particip\u00e9 patients, aidants, infirmiers et autres professionnels de sant\u00e9. Ces \u00e9tudes ont permis de tester les am\u00e9liorations apport\u00e9es \u00e0 la seringue pr\u00e9-remplie existante.1 Parmi les nouvelles fonctionnalit\u00e9s, on peut citer les modifications apport\u00e9es \u00e0 l\u2019ergonomie et \u00e0 la manipulation, un nouveau capuchon protecteur de l\u2019aiguille, un proc\u00e9d\u00e9 d\u2019injection avec support de piston et une am\u00e9lioration de la facilit\u00e9 d\u2019utilisation.1 Le syst\u00e8me automatique int\u00e9gr\u00e9, qui \u00e9vite les blessures par piq\u00fbre d\u2019aiguille gr\u00e2ce au verrouillage apr\u00e8s administration, n\u2019a pas \u00e9t\u00e9 modifi\u00e9.<\/p>\n<blockquote><p>\u00ab <em>Le lancement europ\u00e9en de la nouvelle seringue pr\u00e9-remplie de Somatuline\u00ae Autogel\u00ae offre une nouvelle option th\u00e9rapeutique pr\u00e9cieuse pour les patients souffrant d\u2019acrom\u00e9galie et de TNE, et constitue une \u00e9tape importante de notre engagement pour une innovation centr\u00e9e sur les patients<\/em>, \u00bb d\u00e9clare Bartek Bednarz, Vice-Pr\u00e9sident Senior d\u2019Ipsen, franchise Oncologie mondiale. \u00ab <em>Nous sommes \u00e9galement tr\u00e8s fiers de pr\u00e9senter sous forme de poster dans le cadre de la conf\u00e9rence ENETS 2019 les r\u00e9sultats de plusieurs \u00e9tudes au cours desquelles nous avons test\u00e9, am\u00e9lior\u00e9 et valid\u00e9 les modifications \u00e0 chaque stade de la proc\u00e9dure d\u2019injection de Somatuline\u00ae Autogel\u00ae \u00bb, <\/em>ajoute Sotirios Stergiopoulos, Chief Medical Officer d\u2019Ipsen.<\/p>\n<p><em>\u00ab Les TNE et l\u2019acrom\u00e9galie peuvent causer de nombreux sympt\u00f4mes g\u00eanants et d\u00e9sagr\u00e9ables. Toute innovation permettant de soulager les patients et d\u2019aider l\u2019\u00e9quipe m\u00e9dicale constitue une v\u00e9ritable avanc\u00e9e, \u00bb <\/em>a d\u00e9clar\u00e9 Daphne T Adelman, Infirmi\u00e8re clinique sp\u00e9cialiste \u00e0 la Northwestern University de Chicago, \u00c9tats-Unis, qui fait partie des auteurs de l\u2019\u00e9tude.<\/p><\/blockquote>\n<p id=\"gnw_attachments_section-header\"> <strong>Pi\u00e8ce jointe<\/strong><\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li> <a target=\"_blank\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=1-MxQiOLzuHsrSXh9zmA3fF8fDJ8R-fcaWoxNogoTxO9fGF7iBCvMy0DKHnKvuGNBnjFhq-RYqoTiyW6kaxEmjPJcXZVgL3GlvfE8qoxVUgMINWx5dWm-iUnm_M2pVe_xGpdRla4UWUxoi_K6QiNvznRaQQPfGcSmQNwBJ6sp-rLrn0tR5SvopSFxWNHC_YV\" title=\"FR-Ipsen_ENETS_Abstract_FINAL\" rel=\"nofollow noopener\">FR-Ipsen_ENETS_Abstract_FINAL<\/a><\/li>\n<\/ul>\n<p><img src='https:\/\/ml-eu.globenewswire.com\/media\/OWZlODJiZmItYTQzNi00OWUyLWI4NTQtYTk4ZmUzNTI3Y2I5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png' \/><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"template":"","categories":[1233,3556],"tags":[],"class_list":["post-36987","press_release","type-press_release","status-publish","hentry","category-pressrelease-fr","category-corporate-pressrelease-fr","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ipsen pr\u00e9sentera les am\u00e9liorations apport\u00e9es \u00e0 la seringue pr\u00e9-remplie de Somatuline\u00ae Autogel\u00ae lors de la 16e Conf\u00e9rence annuelle de l\u2019ENETS (European Neuroendocrine Tumor Society)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ipsen pr\u00e9sentera les am\u00e9liorations apport\u00e9es \u00e0 la seringue pr\u00e9-remplie de Somatuline\u00ae Autogel\u00ae lors de la 16e Conf\u00e9rence annuelle de l\u2019ENETS (European Neuroendocrine Tumor Society)\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-06T16:50:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml-eu.globenewswire.com\/media\/OWZlODJiZmItYTQzNi00OWUyLWI4NTQtYTk4ZmUzNTI3Y2I5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/\"},\"author\":{\"name\":\"IPSEN\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0\"},\"headline\":\"Ipsen pr\u00e9sentera les am\u00e9liorations apport\u00e9es \u00e0 la seringue pr\u00e9-remplie de Somatuline\u00ae Autogel\u00ae lors de la 16e Conf\u00e9rence annuelle de l\u2019ENETS (European Neuroendocrine Tumor Society)\",\"datePublished\":\"2019-03-06T06:00:00+00:00\",\"dateModified\":\"2023-09-06T16:50:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/\"},\"wordCount\":495,\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/OWZlODJiZmItYTQzNi00OWUyLWI4NTQtYTk4ZmUzNTI3Y2I5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"articleSection\":[\"Communiqu\u00e9 de presse\",\"Corporate\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/\",\"url\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/\",\"name\":\"Ipsen pr\u00e9sentera les am\u00e9liorations apport\u00e9es \u00e0 la seringue pr\u00e9-remplie de Somatuline\u00ae Autogel\u00ae lors de la 16e Conf\u00e9rence annuelle de l\u2019ENETS (European Neuroendocrine Tumor Society)\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/OWZlODJiZmItYTQzNi00OWUyLWI4NTQtYTk4ZmUzNTI3Y2I5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"datePublished\":\"2019-03-06T06:00:00+00:00\",\"dateModified\":\"2023-09-06T16:50:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/#primaryimage\",\"url\":\"https:\/\/ml-eu.globenewswire.com\/media\/OWZlODJiZmItYTQzNi00OWUyLWI4NTQtYTk4ZmUzNTI3Y2I5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"contentUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/OWZlODJiZmItYTQzNi00OWUyLWI4NTQtYTk4ZmUzNTI3Y2I5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ipsen pr\u00e9sentera les am\u00e9liorations apport\u00e9es \u00e0 la seringue pr\u00e9-remplie de Somatuline\u00ae Autogel\u00ae lors de la 16e Conf\u00e9rence annuelle de l\u2019ENETS (European Neuroendocrine Tumor Society)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0\",\"name\":\"IPSEN\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g\",\"caption\":\"IPSEN\"},\"sameAs\":[\"https:\/\/www.ipsen.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ipsen pr\u00e9sentera les am\u00e9liorations apport\u00e9es \u00e0 la seringue pr\u00e9-remplie de Somatuline\u00ae Autogel\u00ae lors de la 16e Conf\u00e9rence annuelle de l\u2019ENETS (European Neuroendocrine Tumor Society)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/","og_locale":"fr_FR","og_type":"article","og_title":"Ipsen pr\u00e9sentera les am\u00e9liorations apport\u00e9es \u00e0 la seringue pr\u00e9-remplie de Somatuline\u00ae Autogel\u00ae lors de la 16e Conf\u00e9rence annuelle de l\u2019ENETS (European Neuroendocrine Tumor Society)","og_url":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/","og_site_name":"Global","article_modified_time":"2023-09-06T16:50:34+00:00","og_image":[{"url":"https:\/\/ml-eu.globenewswire.com\/media\/OWZlODJiZmItYTQzNi00OWUyLWI4NTQtYTk4ZmUzNTI3Y2I5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png"}],"twitter_card":"summary_large_image","twitter_site":"@ipsengroup","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/#article","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/"},"author":{"name":"IPSEN","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0"},"headline":"Ipsen pr\u00e9sentera les am\u00e9liorations apport\u00e9es \u00e0 la seringue pr\u00e9-remplie de Somatuline\u00ae Autogel\u00ae lors de la 16e Conf\u00e9rence annuelle de l\u2019ENETS (European Neuroendocrine Tumor Society)","datePublished":"2019-03-06T06:00:00+00:00","dateModified":"2023-09-06T16:50:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/"},"wordCount":495,"publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/media\/OWZlODJiZmItYTQzNi00OWUyLWI4NTQtYTk4ZmUzNTI3Y2I5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png","articleSection":["Communiqu\u00e9 de presse","Corporate"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/","url":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/","name":"Ipsen pr\u00e9sentera les am\u00e9liorations apport\u00e9es \u00e0 la seringue pr\u00e9-remplie de Somatuline\u00ae Autogel\u00ae lors de la 16e Conf\u00e9rence annuelle de l\u2019ENETS (European Neuroendocrine Tumor Society)","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/#primaryimage"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/media\/OWZlODJiZmItYTQzNi00OWUyLWI4NTQtYTk4ZmUzNTI3Y2I5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png","datePublished":"2019-03-06T06:00:00+00:00","dateModified":"2023-09-06T16:50:34+00:00","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/#primaryimage","url":"https:\/\/ml-eu.globenewswire.com\/media\/OWZlODJiZmItYTQzNi00OWUyLWI4NTQtYTk4ZmUzNTI3Y2I5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png","contentUrl":"https:\/\/ml-eu.globenewswire.com\/media\/OWZlODJiZmItYTQzNi00OWUyLWI4NTQtYTk4ZmUzNTI3Y2I5LTEwMTA5NDM=\/tiny\/Ipsen-SA.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-presentera-les-ameliorations-apportees-a-la-seringue-pre-remplie-de-somatuline-autogel-lors-de-la-16e-conference-annuelle-de-lenets-european-neuroendocrine-tumor-society\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Ipsen pr\u00e9sentera les am\u00e9liorations apport\u00e9es \u00e0 la seringue pr\u00e9-remplie de Somatuline\u00ae Autogel\u00ae lors de la 16e Conf\u00e9rence annuelle de l\u2019ENETS (European Neuroendocrine Tumor Society)"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/fr\/#website","url":"https:\/\/www.ipsen.com\/fr\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/fr\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]},{"@type":"Person","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0","name":"IPSEN","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g","caption":"IPSEN"},"sameAs":["https:\/\/www.ipsen.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release\/36987"}],"collection":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release"}],"about":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/types\/press_release"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":2,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release\/36987\/revisions"}],"predecessor-version":[{"id":36993,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release\/36987\/revisions\/36993"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media?parent=36987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/categories?post=36987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/tags?post=36987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}